Amphotericin B microspheres: A therapeutic approach to minimize toxicity while maintaining antifungal efficacy

References

• Atkinson AJBJE. Amphotericin B pharmacokinetics in humans. Antimicrob Agents Chemother 1978; 13: 271–276
   PubMed Web of Science ®Google Scholar
• Benedetti E, Gruessner AC, Troppmann C, Papalois BE, Sutherland DE, Dunn DL, Gruessner RW. Intra-abdominal fungal infections after pancreatic transplantation: Incidence, treatment, and outcome. J Am Coll Surg 1996; 183: 307–316
   PubMedGoogle Scholar
• Branch R. Prevention of amphotericin B-induced renal impairment: A review on the use of sodium supplementation. Arch Intern Med 1988; 148: 2389–2394
   PubMed Web of Science ®Google Scholar
• Burgess JBR. Nephrotoxicity of amphotericin B, with emphasis on changes in tubular function. Am J Med 1972; 53: 77–84
   PubMed Web of Science ®Google Scholar
• Carlson KC, Mehlmauer M, Evans S, Chandrasoma P. Cryptococcal cellulitis in renal transplant recipients. J Am Acad Dermatol 1987; 17: 469–472
   PubMed Web of Science ®Google Scholar
• Carnevale NT, Galgiani JN, Stevens DA, Herrick MK, Langston JW. Amphotericin B-induced myelopathy. Arch Intern Med 1980; 140: 1189–1192
   PubMed Web of Science ®Google Scholar
• Chuck SL, Sande MA. Infections with Cryptococcus neoformans in the acquired immunodeficiency syndrome. N Engl J Med 1989; 321: 794–799
   PubMed Web of Science ®Google Scholar
• Chugh KS, Sakhuja V, Jain S, Singh V, Tarafdar A, Joshi K, Gupta KL, Minz M. Fungal infections in renal allograft recipients. Transplant Proc 1992; 24: 1940–1942
   PubMed Web of Science ®Google Scholar
• Correia FM, Petri DF, Carmona-Ribeiro AM. Colloid stability of lipid/polyelectrolyte decorated latex. Langmuir 2004; 20: 9535–9540
   PubMedGoogle Scholar
• Cutler JE. Putative virulence factors of Candida albicans. Annu Rev Microbiol 1991; 45: 187–218
   PubMed Web of Science ®Google Scholar
• D'Souza M, DeSouza P. Preparation and testing of cyclosporine microsphere and solution formulations in the treatment of polyarthritis in rats. Drug Dev Ind Pharm 1998; 24: 841–852
   PubMed Web of Science ®Google Scholar
• D'Souza M, Pourfarzib R. Improved efficacy of a microencapsulated macrophage colony stimulating factor and methotrexate in melanoma. Drug Dev Ind Pharm 1999; 25: 585–592
   Google Scholar
• D'Souza MJ, DeSouza PJ. Site specific microencapsulated drug targeting strategies to the liver and the gastrointestinal tract. Adv Drug Del Rev 1995; 17: 247–254
   Web of Science ®Google Scholar
• D'Souza MJ, Jin Z, Oettinger CW. Treatment of experimental septic shock with microencapsulated antisense oligomers to NF-kappaB. J Interferon Cytokine Res 2005; 25: 311–320
   PubMed Web of Science ®Google Scholar
• Escabi-Mendoza JE, Martinez-Diaz JD, Aviles-Rivera ED. Perflutren microspheres for contrast echocardiography in a bloody pericardiocentesis. Tex Heart Inst J 2006; 33: 214–217
   PubMedGoogle Scholar
• Gerber DA, Oettinger CW, D'Souza M, Milton GV, Larsen CP, Pearson TC. Prolongation of murine cardiac allograft survival by microspheres containing TNF alpha and IL1-beta neutralizing antibodies. J Drug Target 1995; 3: 311–315
   PubMed Web of Science ®Google Scholar
• Green M, D'Souza MJ, Holbrook JM, Wirtz RA. In-vivo and in-vitro evaluation of albumin-encapsulated primaquine diphosphate prepared by nebulization into heated oil. J Microencapsulation 2004; 21: 433–444
   PubMed Web of Science ®Google Scholar
• Haswani DK, Nettey H, D'Souza MJ, Oettinger CW. In vitro evaluation and targeting of E. coli internalized by endothelial cells using albumin microspheres loaded with gentamicin. Drug Dev Ind Pharm 2007; 33: 181–190
   PubMed Web of Science ®Google Scholar
• Haswani DK, Nettey H, Oettinger C, D'Souza MJ. Formulation, characterization and pharmacokinetic evaluation of gentamicin sulphate loaded albumin microspheres. J Microencapsulation 2006; 23: 875–886
   PubMed Web of Science ®Google Scholar
• Heidemann HT, Gerkens JF, Spickard WA, Jackson EK, Branch RA. Amphotericin B nephrotoxicity in humans decreased by salt repletion. Am J Med 1983; 75: 476–481
   PubMed Web of Science ®Google Scholar
• Jabbour N, Reyes J, Kusne S, Martin M, Fung J. Cryptococcal meningitis after liver transplantation. Transplantation 1996; 61: 146–149
   PubMed Web of Science ®Google Scholar
• Murray L. Redbook 2006 pharmacy's fundamental reference. Thomson, Montvale, NJ 2006
   Google Scholar
• NCCLS. Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard, NCCLS, Wayne, PA 2002
   Google Scholar
• Odds FC. Candida albicans proteinase as a virulence factor in the pathogenesis of Candida infections. Zentralbl Bakteriol Mikrobiol Hyg [A] 1985; 260: 539–542
   PubMedGoogle Scholar
• Odds FC. Pathogenesis of Candida infections. J Am Acad Dermatol 1994; 31: S2–S5
   PubMed Web of Science ®Google Scholar
• Oettinger C, D'Souza M. Microencapsulation of tumor necrosis factor oligomers: A new approach to proinflammatory cytokine inhibition. J Interferon Cytokine Res 2003; 23: 533–543
   PubMed Web of Science ®Google Scholar
• Oettinger CW, D'Souza MJ, Akhavein N, Peer GT, Taylor FB, Kinasewitz GT. Pro-inflammatory cytokine inhibition in the primate using microencapsulated antisense oligomers to NF-kappaB. J Microencapsulation 2007; 24: 337–348
   PubMed Web of Science ®Google Scholar
• Paterson DL, Singh N. Invasive aspergillosis in transplant recipients. Medicine (Baltimore) 1999; 78: 123–138
   PubMed Web of Science ®Google Scholar
• Ruiz-Arango A, Landolfo C. A novel approach to the diagnosis of left atrial appendage thrombus using contrast echocardiography and power Doppler imaging. Eur J Echocardiogr 2008; 9: 329–333
   PubMedGoogle Scholar
• Sanchez-Brunete JA, Dea MA, Rama S, Bolas F, Alunda JM, Raposo R, Mendez MT, Torrado-Santiago S, Torrado JJ. Treatment of experimental visceral leishmaniasis with amphotericin B in stable albumin microspheres. Antimicrob Agents Chemother 2004; 48: 3246–3252
   PubMed Web of Science ®Google Scholar
• Sanchez-Brunete JA, Dea MA, Rama S, Bolas F, Alunda JM, Torrado-Santiago S, Torrado JJ. Influence of the vehicle on the properties and efficacy of microparticles containing amphotericin B. J Drug Target 2005; 13: 225–233
   PubMed Web of Science ®Google Scholar
• Vieira DB, Carmona-Ribeiro AM. Cationic nanoparticles for delivery of amphotericin B: Preparation, characterization and activity in vitro. J Nanobiotechnol 2008; 6: 6
   PubMedGoogle Scholar
• William HT, Bennett RE. Streptomyces nodosus sp. N., the Amphotericin-producing organism. J Bacteriol 1963; 85: 436–439
   PubMedGoogle Scholar
• Wong-Beringer A, Jacobs RA, Guglielmo BJ. Lipid formulations of amphotericin B: Clinical efficacy and toxicities. Clin Infect Dis 1998; 27: 603–618
   PubMed Web of Science ®Google Scholar
• Young RF, Gade G, Grinnell V. Surgical treatment for fungal infections in the central nervous system. J Neurosurg 1985; 63: 371–381
   PubMed Web of Science ®Google Scholar
• Zuger A, Louie E, Holzman RS, Simberkoff MS, Rahal JJ. Cryptococcal disease in patients with the acquired immunodeficiency syndrome. Diagnostic features and outcome of treatment. Ann Intern Med 1986; 104: 234–240
   PubMed Web of Science ®Google Scholar